featured
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With ER+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial
J. Clin. Oncol 2022 Apr 20;[EPub Ahead of Print], SB Vliek, I Noordhoek, E Meershoek-Klein Kranenbarg, AGJ van Rossum, VO Dezentje, A Jager, JWE Hokken, H Putter, AWG van der Velden, MP Hendriks, SD Bakker, YEA van Riet, VCG Tjan-Heijnen, JEA Portielje, JR Kroep, JWR Nortier, CJH van de Velde, SC LinnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.